R-Spondin1保护胃干细胞并减轻异基因造血干细胞移植中的胃移植物抗宿主病
本文在小鼠模型中研究胃移植物抗宿主病(GVHD)对Lgr5阳性胃干细胞(GSCs)的影响,发现实验性异基因造血细胞移植后Lgr5+ GSCs显著减少,壁细胞受损导致胃酸化失败和十二指肠需氧菌过度生长。给予R-Spondin1可保护Lgr5+ GSCs,减轻胃GVHD,恢复胃酸化并抑制十二指肠需氧菌过度生长。
要点
- 实验性异基因造血细胞移植后Lgr5+胃干细胞显著减少,胃GVHD中壁细胞受损。
- 胃酸化失败导致十二指肠需氧菌过度生长。
- R-Spo1保护Lgr5+胃干细胞,减轻胃GVHD并恢复胃酸化。
核心结论
- Lgr5+胃干细胞是胃GVHD的靶点,导致胃稳态破坏,而R-Spo1保护Lgr5+胃干细胞免受GVHD并维持胃稳态。
研究设计与样本
- 小鼠实验性异基因造血细胞移植(allo-HCT)研究,包含命运图谱分析。
主要发现
- 实验性allo-HCT后Lgr5+胃干细胞显著减少。
- 胃GVHD中壁细胞受损,导致胃酸化失败和十二指肠需氧菌过度生长。
- 在naïve小鼠中给予结合Lgr5的R-Spo1 6天,显著增加源自Lgr5+胃干细胞的增殖上皮细胞。
- 在allo-HCT第-3至-1天及第+1至+3天给予R-Spo1,保护胃干细胞,减轻胃GVHD,恢复胃酸化并抑制十二指肠需氧菌过度生长。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Graft-versus-host disease (GVHD) is the major obstacle to performing allogeneic hematopoietic cell transplantation (allo-HCT). We and others have shown that intestinal stem cells are targeted in lower gastrointestinal GVHD. A leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5)-expressing gastric stem cells (GSCs) reside at the base of the gastric glands in mice. After experimental allo-HCT, Lgr5+ GSCs significantly decreased. Parietal cells, which underwent continuous renewal by GSCs, were injured in gastric GVHD, leading to failure of gastric acidification and aerobic bacterial overgrowth in the duodenum. Fate-mapping analysis demonstrated that administration of R-Spondin1 (R-Spo1) that binds to Lgr5 for 6 days in naïve mice significantly increased proliferating epithelial cells derived from Lgr5+ GSCs. R-Spo1 administered on days -3 to -1 and from days +1 to +3 of allo-HCT protected GSCs, leading to amelioration of gastric GVHD and restoration of gastric acidification, and suppression of aerobic bacterial overgrowth in the duodenum. In conclusion, Lgr5+ GSCs were targeted by gastric GVHD, resulting in disruption of the gastric homeostasis, whereas R-Spo1 protected Lgr5+ GSCs from GVHD and maintained homeostasis in the stomach.
引用
- Hayase E, Ara T, Saito Y, et al. R-Spondin1 protects gastric stem cells and mitigates gastric GVHD in allogeneic hematopoietic stem cell transplantation. Blood Adv. 2024. PMID: 38147622. doi:10.1182/bloodadvances.2023011034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。